Company Profile
Access
Contact Us
Contact Us

Tamotsu Sudo（Kanto/Tokyo）

Cancer Diagnosis
　　　　　　　　　Professor　Sudo　

　　　　　　　　　Professor　Sudo　

Fujita Health University Haneda Clinic

Fujita Health University Haneda Clinic

　　　　　　　　　Professor　Sudo　
Fujita Health University Haneda Clinic

Professor, Department of Genomic Medicine, Fujita Health University School of Medicine Director, Hospital Cancer Center

Specialist in Cancer Genomic Medicine


We provide advanced cancer diagnostics using the latest genome analysis. Under the expert guidance of Professor Tamotsu Sudo, a leader in Japan's cancer genomic medicine, we conduct comprehen- sive tests, including cancer genome and hereditary cancer screening. By analyzing your genes and those of cancer cells, we can offer accurate diagno- ses and personalized treatment options.

Clinical department/Main areas of expertise
  • Cancer Diagnosis
    Professor, Department of Genomic Medicine, Fujita Health University School of Medicine Director, Hospital Cancer Center　Detail
Specialized area
  • Cancer Genome Testing
    Cancer Gene Panel Testing (CGP)


    Hereditary Cancer Testing
    Multi-Gene Panel Testing (MGPT)　Detail
Qualifications/Academia/Position
  • Specialist and Certified Medical Instructor of Obstetrics and Gynecology (Japan Society of Obstetrics and Gynecology)
  • Certified Occupational Physician (Japan Medical Association)
Affiliated hospital
FUJITA HEALTH UNIVERSITY HANEDA CLINIC
location
〒144-0041
1-1-4, Hanedakuko, Ota-ku, Haneda Innovation City Zone A Google Map Map
Biography
1994
Graduate, Faculty of Medicine, Yamaguchi University
1994
Perinatal Medicine Center, Kobe University Hospital
2001
PhD, Graduate School of Medical Sciences, Kumamoto University
2001
Postdoctoral Fellow, MD Anderson Cancer Center, Texas
2012
Director of Research and Gynecology, Hyogo Cancer Center
April 2023
Professor, Department of Clinical Oncology, Fujita Health University
September 2023
Professor, Department of Genomic Medicine, Fujita Health University School of Medicine Director, Hospital Cancer Center
paper
  • 1. Pigment epithelium-derived factor promotes peritoneal dissemination of ovarian cancer through induction of immunosuppressive macrophages. Ueno S, Sudo T, Saya H, Sugihara E. Commun Biol. 2022 Sep 2;5(1):904
  • 2. Response to entrectinib in a malignant glioneuronal tumor with ARHGEF2-NTRK fusion. Kazuhiko Kurozumi, Kentaro Fujii, Kana Washio, Joji Ishida, Yoshihiro Otani, Tamotsu Sudo, Makoto Tahara, Koichi Ichimura, Ennishi Daisuke, Isao Date. Neuro-Oncology Advances, 13 June 2022
  • 3. ATM: Functions of ATM Kinase and Its Relevance to Hereditary Tumors. Ueno S, Sudo T, Hirasawa A. Int J Mol Sci. 2022 Jan 4;23(1):523
others
■ Main Research
I am working towards the implementation of more appropriate cancer genomics and hereditary tumor care in society.

■ Awards
1. Best Presentation Award. 2012 Annual Meeting of Japan Obstetrics and Gynecology Association
2. Best Poster Award. 2009 Annual Meeting of Japan Society of Clinical Oncology
3. Best Presentation Award. 2007 and 2008 Annual Meeting of Japan Obstetrics and Gynecology Association
4. AACR-Bristol-Myers Squibb Scholar-in-Training Award AACR 95th Annual Meeting, 2004
5. Uehara Memorial Foundation Overseas Research Fellowship Grant, 2003
6. Sumitomo Life Social Welfare Services Foundation research fellowship, 2002

Boston Gene Tumor Portrait™ Test
The Only Facility in Japan × Next-Generation Cancer Genomic Testing
Whole Exome Sequencing
＋ Dual-Panel with RNA Sequencing
Comprehensive analysis of approx. 22,000 genes
It can fully visualize the entire tumor landscape at a scale beyond traditional tests
(100-700 genes).
Simultaneous analysis of DNA and RNA
Allows for a deeper understanding of cancer progression and treatment
responsiveness.
Microenvironment (TME) Analysis
Evaluates the entire cancer environment and predicts the most effective treatment
It allows for the pre-assessment of the effectiveness of immune checkpoint inhibitors and other treatments.

This doctor's treatment program

  • Inquiry about Second Opinion Program for Surgery by Dr. Sudo　(Fujita Health University Haneda Clinic)

    FUJITA HEALTH UNIVERSITY HANEDA CLINIC（Kanto/Tokyo）

    Inquiry about Second Opinion Program for Surgery by Dr. Sudo　(Fujita Health University Haneda Clinic)

    See details
Back to search results list Return to "facilities"